Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Summary

The purpose of this clinical research study is to learn if human immunodeficiency virus (HIV)-infected subjects with abdominal fat accumulation on their highly active antiretroviral treatment (HAART) regimen have better changes in fat distribution after switching to atazanavir-ritonavir than those remaining on their current protease inhibitor boosted HAART regimen.

Timeline

Start

2005-07

Primary completion

2007-07

Completion

2008-06

Drugs

Indications